8-K
Current Report
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-039770
Material agreement · Unregistered share sale · Executive or director change · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading xfor-20250811.htm…